Endospan - Transforming Treatment of Life-Threatening Aortic Arch Disease
Endospan brings together a seasoned team of researchers, engineers and executives in the MedTech field. Backed by leading global venture groups, Endospan is focused on becoming a dominant competitor in the endovascular aortic repair market.
The Endospan platform is innovative, opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The novel design of Endospan’s systems presents a true advancement when compared to traditional EVAR/TEVAR systems, enhancing endografts with gold-standard material durability, intra-procedural stability, and a shorter, simpler and less-invasive procedure.
Chief Executive Officer
Vice President, Sales and Marketing
Chief Financial Officer
Vice President, Operations
Vice President, Research & Development
Senior Manager Clinical Affairs
Vice President, Regulatory and Quality
Kevin Mayberry, CEO